Abstract
This study compared two downstream methodologies of antivenom production and statistically evaluated the results of quality control between batches of Antiloxoscelic Serum (approved or not) of these methods. The methodologies present significant downstream differences related to the quality control results. The document analysis and statistical evaluation of the results were obtained using a control chart. All batches showed physical-chemical results within the specification limits, but not all downstream B results were within the process control limits. In all quantitative results analyzed (total protein, non-protein nitrogen, phenol, total solids, pH, chloride), it was possible to verify that the downstream B samples did not meet the process control criteria established by the control chart. The conclusion is that method B is outside the control of the stipulated production process.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
